JBCHEPHARM Cash Flow
- Market cap
- ₹38,793 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,739.59 – ₹3,261.74
In the year ended FY25, JBCHEPHARM generated ₹2,328 crore from operating activities, invested ₹1,552 crore and paid out ₹582 crore on financing activities. Net cash flow for the year was ₹194 crore. Free cash flow was ₹970 crore.
JBCHEPHARM cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 2,328 |
| Cash from investing activities | -1,552 |
| Cash from financing activities | -582 |
| Net cash flow | 194 |
| Capital expenditure | 1,358 |
| Free cash flow | 970 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
JBCHEPHARM cash flow — frequently asked questions
What is JBCHEPHARM's operating cash flow?
JBCHEPHARM's cash flow from operating activities was ₹2,328 crore in the year ended FY25.
What is JBCHEPHARM's free cash flow?
JBCHEPHARM's free cash flow — operating cash flow minus capital expenditure — was ₹970 crore in FY25, after capital expenditure of ₹1,358 crore.
How much did JBCHEPHARM spend on investing activities?
Net cash used in investing activities was ₹1,552 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade JBCHEPHARM With ATS
Track JBCHEPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.